Treatment of alcohol addiction syndrome with cytoflavin

Belov V.G.; Parfenov Yu.A.; Okovityĭ S.V.

doi:https://doi.org/

Belov V.G.

Sankt-Peterburgskiĭ gosudarstvennyĭ institut psikhologii i sotsial'noĭ raboty

Parfenov Yu.A.

Saint Petersburg Institute of Bioregulation and Gerontologу, North-Western Branch, Russian Academy of Science

Okovityĭ S.V.

Poliklinika #91;
Sankt-Peterburgskaia gosudarstvennaia khimiko-farmatsevticheskaia akademiia, Sankt-Peterburg

Treatment of alcohol addiction syndrome with cytoflavin

Authors:

Belov V.G., Parfenov Yu.A., Okovityĭ S.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(6‑2): 54‑57

Read: 1176 times

Contact the author

Table of contents

To cite this article:

Belov VG, Parfenov YuA, Okovityĭ SV. Treatment of alcohol addiction syndrome with cytoflavin. S.S. Korsakov Journal of Neurology and Psychiatry. 2013;113(6‑2):54‑57.

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80

Features of parameters of cerebral hemodynamics in patients with alcoholism with different flexibility of cognitive functions. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):96-100

Adjuvant pharmacological modulation with Cytoflavin in rehabilitation at stages 2—3 in patients with acute cerebral insufficiency and post-intensive care syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):78-85

Evaluation of the effectiveness of the drug cytoflavin to improve adaptation to physical activity in athletes with minor cardiac anomalies. Russian Journal of Preventive Medicine. 2025;(5):90-95

The known and new ideas about the mechanism of action and the spectrum of effects of Mexidol. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):22-33

Factors influencing the achievement of remission in patients with alcohol dependence and concomitant psychological disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):21-30

Clinical and instrumental diagnostics of facial neuropathy in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):31-36

Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14

Comparative study of the neuroprotective effects of the drug Cytoflavin and citicoline in a rats model of hemorrhagic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):85-95

Quantitative electroencephalogram in females at different stages of alcohol remission. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):122-126

Abstract:

Forty-seven hospital patients with alcohol-related mental and behavioral disorders were treated at the stage of abstinence syndrome and post-abstinence disorders. Patients were split into two groups: patients of the control group (n=17) received standard therapy. Patients of the second group (n=30) additionally received antihypoxant/antioxidant - cytoflavin. The results revealed that cytoflavin effectively reduced psychopathological symptoms of alcohol addiction.

Keywords:

dependent behavior

alcoholism

antihypoxant

antioxidant

cytoflavin

psychopathological symptoms

treatment efficacy